Vittal Ramesh Setru

Vittal Setru practices at Baystate Medical Center in Springfield, Massachusetts, part of Baystate Health.

Vittal Setru's NPI, 1811120751, was assigned on August 26, 2009. Vittal Setru holds Connecticut license 50784.

Vittal Setru's primary practice is Baystate Medical Center, at 759 Chestnut Street, Springfield, MA 01199 in Hampden County. The practice phone is (413) 794-0000.

Vittal Setru's primary practice is Baystate Medical Center in Springfield, Massachusetts, part of Baystate Health. Vittal Setru is also affiliated with Baystate Noble Hospital. The medical group on file is Baystate Medical Practices. Dmand AI also links Vittal Setru to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Vittal Setru practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Vittal Setru's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Vittal Setru is licensed in Connecticut.

CMS data shows 549 Medicare services from Vittal Setru across 4 procedure codes in 2024, for 309 Medicare patients. Medicare paid $47,022 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 309 Medicare patients who saw Vittal Setru in 2024. The largest group is 75 to 84, with 108 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Vittal Setru's median patient age at 71, with 54% women.

In 2024, Vittal Setru wrote 266 Medicare Part D claims for 165 patients. 83% of them were for generic drugs. CMS names the drug for 82 of them, across 5 drugs with 11 or more claims each, at $16,302 in total drug cost. In 2023, CMS named 83 claims across 5 drugs.

Vittal Setru accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 34 general payments to Vittal Setru from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $260.